You could say that 2024 has been a perfect year for exhibitions. Certainly, it struck the right note between landmark ...

There’s some surprising Jewish history to be found at this annual attraction, where model trains traverse a mini New York ...

First Stamford Place is the new home of Guggenheim Partners' Connecticut office. Photo courtesy of Newmark Group STAMFORD – The ...

2024 was an “on” year for biennials and the calendar was packed with blockbuster shows and market events that took the Artnet ...

The most valuable U.S. team sponsorship during live broadcasts in 2024 belonged to the Los Angeles Dodgers, according to a ...

Guggenheim initiates Reddit with a buy rating, forecasting significant growth and a price target of $210, implying over 28% ...

The Guggenheim's Orphism exhibition includes more than 90 artworks on display in its iconic rotunda, celebrating the 1910s ...

Cryoport (CYRX), and Sartorius (SARTF) stocks win buy from Guggenheim while Maravai LifeSciences (MRVI) was granted a neutral rating. Read more here.

BasqueGlide over the architectural marvel of the Guggenheim Museum in Bilbao, Spain, with captivating drone footage. Experience the shimmering titanium curves, the stunning riverside location, and the ...

Guggenheim analyst Subbu Nambi initiated coverage of Danaher (DHR) with a Buy rating and $275 price target as the firm expands its ...

Guggenheim initiated coverage of Neogen (NEOG) with a Buy rating and $15 price target Pick the best stocks and maximize your portfolio:Discover ...

On Thursday, Guggenheim reaffirmed its Buy rating for Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ: APGE), despite recent clinical trial setbacks in the atopic dermatitis market by competitors.